Protein-coated corrole nanoparticles for the therapy of prostate most cancers cells
Growth of novel therapeutic methods to eradicate malignant tumors is of paramount significance in most cancers analysis. In a latest research, we now have launched a facile protocol for the preparation of corrole-protein nanoparticles (NPs). These NPs include a corrole-core coated with protein. We now report {that a} novel lipophilic corrole, (<b>2</b>)Ga, delivered as human serum albumin (HSA)-coated NPs, displayed antineoplastic exercise in the direction of human prostate most cancers DU-145 cells.
- Cryo-TEM evaluation of those NPs revealed a median diameter of 50.2 ± 8.1 nm with a spherical structure exhibiting low polydispersity.
- In vitro mobile uptake of (<b>2</b>)Ga/albumin NPs was attributable to speedy internalization of the corrole by means of ligand binding-dependent extracellular launch and intercalation of the corrole cargo into the lipid bilayer of the plasma membrane.
- This discovering is in distinction with a beforehand reported research on corrole-protein NPs that displayed mobile uptake through endocytosis.
- Investigation of the non-light-induced mechanism of motion of (<b>2</b>)Ga recommended the induction of necrosis by means of plasma membrane destabilization, impairment of calcium homeostasis, lysosomal stress and rupture, in addition to formation of reactive oxygen species (ROS).
- Ga additionally exhibited potent light-induced cytotoxicity by means of ROS era. These findings exhibit a speedy mobile uptake of (<b>2</b>)Ga/protein NPs together with focused induction of tumor cell necrosis.
Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates medical outcomes
Elevated ranges of pregnancy-associated plasma protein-A (PAPP-A) have been implicated within the pathogenesis of assorted malignancies, together with breast cancers. Breast most cancers is likely one of the most frequent carcinomas and is the second commonest most cancers kind detected in girls of child-bearing age.
All through pregnancy PAPP-A is produced and secreted by the placental syncytiotrophoblast cells; co-incidentally pregnancy-associated breast cancers usually have an aggressive medical course. The parts of the PAPP-A/IGF axis was assessed in a panel of breast most cancers cell strains. Utilizing neutralising antibodies the impression of PAPP-A/IGF axis on cell motility was evaluated.
PAPP-A was expressed in 4 of the twelve breast most cancers cell strainsexamined. Blocking PAPP-A and IGFBP4 with neutralising antibodies considerably decreased motiliy of MDA-MB-231 cells. Upregulation of PAPP-A expression in breast tumours resulted in a pattern in the direction of worse total survival. Notably, PAPP-A expression additionally positively correlated with epithelial-to-mesenchymal transition markers.
In conclusion, these outcomes point out that PAPP-A performs an essentialfunction in breast most cancersdevelopment and it might be a promising therapeutic goal in breast most cancers.
choleratox
Figuring out Antioxidant Proteins by Combining A number of Strategies
Antioxidant proteins play essential roles in stopping free radical oxidation from damaging cells and DNA. They’ve develop into preferrred candidates of illness prevention and therapy. Subsequently, it’s pressing to determine antioxidants from pure compounds.
Since experimental strategies are nonetheless value ineffective, a sequence of computational strategies have been proposed to determine antioxidant proteins. Nonetheless, the efficiency of the present strategies are nonetheless not passable. On this research, a assist vector machine based mostly technique, referred to as Vote9, was proposed to determine antioxidants, through which the sequences have been encoded through the use of the options generated from 9 optimum particular person fashions.
Outcomes from jackknife take a look at demonstrated that Vote9 is comparable with the perfect one of many current predictors for this activity. We hope that Vote9 will develop into a useful gizmo or a minimum of can play a complementary function to the prevailing strategies for figuring out antioxidants.
 RAB11FIP3 Antibody |
|||
| 34950-50ul | SAB | 50ul | EUR 187 |
RAB11FIP3 Antibody |
|||
| 1-CSB-PA080054 | Cusabio |
|
|
|
|||
|
Description: A polyclonal antibody against RAB11FIP3. Recognizes RAB11FIP3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/10000 |
|||
RAB11FIP3 Antibody |
|||
| CSB-PA441575- | Cusabio | EUR 335 | |
|
|||
|
Description: A polyclonal antibody against RAB11FIP3. Recognizes RAB11FIP3 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
RAB11FIP3 Antibody |
|||
| CSB-PA441575-100ul | Cusabio | 100ul | EUR 316 |
|
|||
|
Description: A polyclonal antibody against RAB11FIP3. Recognizes RAB11FIP3 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;IHC:1:50-1:100 |
|||
 Rabbit Polyclonal antibody Anti-CRBN |
|||
| Anti-CRBN | ImmunoStep | 50 µg | EUR 349 |
 RAB11FIP3 Conjugated Antibody |
|||
| C34950 | SAB | 100ul | EUR 397 |
 RAB11FIP3 siRNA |
|||
| 20-abx930591 | Abbexa |
|
|
|
|||
RAB11FIP3 siRNA |
|||
| 20-abx930592 | Abbexa |
|
|
|
|||
 Polyclonal Goat anti-GST α-form |
|||
| GST-ANTI-1 | Detroit R&D | 50 uL | EUR 280 |
 Polyclonal Goat anti-GST μ-form |
|||
| GST-ANTI-2 | Detroit R&D | 50 uL | EUR 280 |
 Polyclonal Goat anti-GST p-form |
|||
| GST-ANTI-3 | Detroit R&D | 50 uL | EUR 280 |
 RAB11FIP3 ELISA KIT|Human |
|||
| EF002213 | Lifescience Market | 96 Tests | EUR 689 |
 Human RAB11FIP3 shRNA Plasmid |
|||
| 20-abx956495 | Abbexa |
|
|
|
|||
 Mouse RAB11FIP3 shRNA Plasmid |
|||
| 20-abx980932 | Abbexa |
|
|
|
|||
 Antibody) Rab11 Family-Interacting Protein 3 (RAB11FIP3) Antibody |
|||
| 20-abx014771 | Abbexa |
|
|
|
|||
Rab11 Family-Interacting Protein 3 (RAB11FIP3) Antibody |
|||
| abx236992-100ug | Abbexa | 100 ug | EUR 551 |
|
|||
 Antibody) Rab11 family-interacting protein 3 (RAB11FIP3) Antibody |
|||
| abx331334-100ul | Abbexa | 100 ul | EUR 425 |
|
|||
Rab11 family-interacting protein 3 (RAB11FIP3) Antibody |
|||
| 20-abx326438 | Abbexa |
|
|
|
|||
 (pORF)) RAB11FIP3 ORF Vector (Human) (pORF) |
|||
| ORF028624 | ABM | 1.0 ug DNA | EUR 405 |
 (pORF)) Rab11fip3 ORF Vector (Mouse) (pORF) |
|||
| ORF055392 | ABM | 1.0 ug DNA | EUR 506 |
Rab11fip3 ORF Vector (Mouse) (pORF) |
|||
| ORF055393 | ABM | 1.0 ug DNA | EUR 506 |
Rab11fip3 ORF Vector (Mouse) (pORF) |
|||
| ORF055394 | ABM | 1.0 ug DNA | EUR 506 |
) Rab11fip3 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K4045501 | ABM | 3 x 1.0 ug | EUR 339 |
) RAB11FIP3 sgRNA CRISPR Lentivector set (Human) |
|||
| K1771301 | ABM | 3 x 1.0 ug | EUR 339 |
 (Target 1)) Rab11fip3 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K4045502 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 2)) Rab11fip3 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K4045503 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 3)) Rab11fip3 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K4045504 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 1)) RAB11FIP3 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K1771302 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 2)) RAB11FIP3 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K1771303 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 3)) RAB11FIP3 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K1771304 | ABM | 1.0 ug DNA | EUR 154 |
 RAB11FIP3 3'UTR Luciferase Stable Cell Line |
|||
| TU019363 | ABM | 1.0 ml | EUR 1521 |
 Rab11fip3 3'UTR Luciferase Stable Cell Line |
|||
| TU117386 | ABM | 1.0 ml | Ask for price |
 Rab11fip3 3'UTR GFP Stable Cell Line |
|||
| TU167386 | ABM | 1.0 ml | Ask for price |
Rab11fip3 3'UTR Luciferase Stable Cell Line |
|||
| TU217172 | ABM | 1.0 ml | Ask for price |
Rab11fip3 3'UTR GFP Stable Cell Line |
|||
| TU267172 | ABM | 1.0 ml | Ask for price |
 RAB11FIP3 3'UTR GFP Stable Cell Line |
|||
| TU069363 | ABM | 1.0 ml | EUR 1521 |
 (pPB-C-His)) RAB11FIP3 Protein Vector (Human) (pPB-C-His) |
|||
| PV114494 | ABM | 500 ng | EUR 811 |
 (pPB-N-His)) RAB11FIP3 Protein Vector (Human) (pPB-N-His) |
|||
| PV114495 | ABM | 500 ng | EUR 811 |
 (pPM-C-HA)) RAB11FIP3 Protein Vector (Human) (pPM-C-HA) |
|||
| PV114496 | ABM | 500 ng | EUR 811 |
 (pPM-C-His)) RAB11FIP3 Protein Vector (Human) (pPM-C-His) |
|||
| PV114497 | ABM | 500 ng | EUR 811 |
 (pPB-C-His)) RAB11FIP3 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV221566 | ABM | 500 ng | EUR 603 |
 (pPB-N-His)) RAB11FIP3 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV221567 | ABM | 500 ng | EUR 603 |
 (pPM-C-HA)) RAB11FIP3 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV221568 | ABM | 500 ng | EUR 603 |
 (pPM-C-His)) RAB11FIP3 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV221569 | ABM | 500 ng | EUR 603 |
RAB11FIP3 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV221570 | ABM | 500 ng | EUR 1065 |
RAB11FIP3 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV221571 | ABM | 500 ng | EUR 1065 |
RAB11FIP3 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV221572 | ABM | 500 ng | EUR 1065 |
RAB11FIP3 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV221573 | ABM | 500 ng | EUR 1065 |
RAB11FIP3 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV221574 | ABM | 500 ng | EUR 1065 |
RAB11FIP3 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV221575 | ABM | 500 ng | EUR 1065 |
RAB11FIP3 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV221576 | ABM | 500 ng | EUR 1065 |
RAB11FIP3 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV221577 | ABM | 500 ng | EUR 1065 |
 Mouse Rab11 family- interacting protein 3, Rab11fip3 ELISA KIT |
|||
| ELI-52646m | Lifescience Market | 96 Tests | EUR 865 |
 ELISA Kit) Human Rab11 family-interacting protein 3 (RAB11FIP3) ELISA Kit |
|||
| abx382597-96tests | Abbexa | 96 tests | EUR 911 |
|
|||
 Human Rab11 family- interacting protein 3, RAB11FIP3 ELISA KIT |
|||
| ELI-41089h | Lifescience Market | 96 Tests | EUR 824 |
ELISA Kit) Human RAB11 Family Interacting Protein 3(RAB11FIP3)ELISA Kit |
|||
| QY-E04676 | Qayee Biotechnology | 96T | EUR 361 |
) ELISA kit for Human Rab11 family-interacting protein 3 (RAB11FIP3) |
|||
| KTE63067-48T | Abbkine | 48T | EUR 354 |
|
Description: Quantitative sandwich ELISA for measuring Human Rab11 family-interacting protein 3 (RAB11FIP3) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Rab11 family-interacting protein 3 (RAB11FIP3) |
|||
| KTE63067-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 2252 |
|
Description: Quantitative sandwich ELISA for measuring Human Rab11 family-interacting protein 3 (RAB11FIP3) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Rab11 family-interacting protein 3 (RAB11FIP3) |
|||
| KTE63067-96T | Abbkine | 96T | EUR 572 |
|
Description: Quantitative sandwich ELISA for measuring Human Rab11 family-interacting protein 3 (RAB11FIP3) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
) Rab11fip3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
| K4045505 | ABM | 3 x 1.0 ug | EUR 376 |
) RAB11FIP3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K1771305 | ABM | 3 x 1.0 ug | EUR 376 |
 (Target 1)) Rab11fip3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
| K4045506 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 2)) Rab11fip3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
| K4045507 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 3)) Rab11fip3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
| K4045508 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 1)) RAB11FIP3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K1771306 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 2)) RAB11FIP3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K1771307 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 3)) RAB11FIP3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K1771308 | ABM | 1.0 ug DNA | EUR 167 |
 Anti-Anti-SEPT6 antibody antibody |
|||
| STJ11100949 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
|||
 Anti-Anti-SEPT9 Antibody antibody |
|||
| STJ111369 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
|||
 Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ111530 | St John's Laboratory | 100 µl | EUR 277 |
 Anti-Anti-SEPT4 Antibody antibody |
|||
| STJ112276 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
|||
 Anti-Anti-SEPT2 Antibody antibody |
|||
| STJ25475 | St John's Laboratory | 100 µl | EUR 277 |
 Anti-Anti-SEPT5 Antibody antibody |
|||
| STJ25477 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
 Anti-Anti-SEPT8 Antibody antibody |
|||
| STJ25479 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-SEPT2 Antibody antibody |
|||
| STJ28365 | St John's Laboratory | 100 µl | EUR 277 |
 Anti-Anti-SEPT7 Antibody antibody |
|||
| STJ28963 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
 Anti-Anti-MARCH9 Antibody antibody |
|||
| STJ112609 | St John's Laboratory | 100 µl | EUR 277 |
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ113941 | St John's Laboratory | 100 µl | EUR 277 |
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ114081 | St John's Laboratory | 100 µl | EUR 277 |
Anti-Anti-SEPT5 Antibody antibody |
|||
| STJ114819 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
 Anti-Anti-MARCH8 Antibody antibody |
|||
| STJ114828 | St John's Laboratory | 100 µl | EUR 277 |
Anti-Anti-SEPT7 Antibody antibody |
|||
| STJ116214 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
Anti-Anti-SEPT8 Antibody antibody |
|||
| STJ117206 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
 Anti-Anti-SEPT12 Antibody antibody |
|||
| STJ117759 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
|||
 Anti-Anti-MARCH6 Antibody antibody |
|||
| STJ118549 | St John's Laboratory | 100 µl | EUR 277 |
Anti-Anti-MARCH6 Antibody antibody |
|||
| STJ118550 | St John's Laboratory | 100 µl | EUR 277 |
 Anti-Anti-MARCH7 Antibody antibody |
|||
| STJ118752 | St John's Laboratory | 100 µl | EUR 277 |
Immunodominant Mycobacterium tuberculosis Protein Rv1507A Elicits Th1 Response and Modulates Host Macrophage Effector Features
Mycobacterium tuberculosis (M. tb) persists as latent an infection in practically 1 / 4 of the worldwide inhabitants and stays the main reason behind dying amongst infectious ailments. Whereas BCG is the one vaccine for TB, its lack of ability to offer full safety makes it crucial to engineer BCG such that it expresses immunodominant antigens that may improve its protecting potential.
In-silico comparative genomic evaluation of Mycobacterium species recognized M. tb Rv1507A as a “signature protein” discovered solely in M. tb. In-vitro (cell strains) and in-vivo experiments carried out in mice, utilizing purified recombinant Rv1507A revealed it to be a pro-inflammatory molecule, eliciting considerably excessive ranges of IL-6, TNF-α, and IL-12.
There was elevated expression of activation markers CD69, CD80, CD86, antigen presentation molecules (MHC I/MHCII), and related Th1 kind of immune response. Rv1507A knocked-in M. smegmatis additionally induced considerably greater pro-inflammatory Th1 response and better survivability underneath stress situations, each in-vitro (macrophage RAW264.7 cells) and in-vivo (mice).
Sera derived from human TB sufferers confirmed considerably enhanced B-cell response towards M. tb Rv1507A. The power of M. tb Rv1507A to induce immuno-modulatory impact, B cell response, and important reminiscence response, renders it a putative vaccine candidate that calls for additional exploration.
 IgG (mixture of EVZ12-M and EVZ13-M), aff pure) Mouse Monoclonal Anti-Zaire Ebola virus (killed) IgG (mixture of EVZ12-M and EVZ13-M), aff pure |
|||
| EVZ14-M | Alpha Diagnostics | 100 ul | EUR 482 |
 IgG #2) Monoclonal Anti-M. tuberculosis 10 Kda cultural filtrate protein (CFP10) IgG #2 |
|||
| CFP102-M | Alpha Diagnostics | 100 ul | EUR 482 |
 IgG) Monoclonal Anti-M. tuberculosis Heat Shock Protein 70 (hsp70/Dnak/ML2496) IgG |
|||
| HSP701-M | Alpha Diagnostics | 100 ul | EUR 482 |
 IgG) Monoclonal Anti-M. tuberculosis Heat Shock Protein 65 (hsp65/groEL-2/Cpn60-2) IgG |
|||
| HSP651-M | Alpha Diagnostics | 100 ul | EUR 482 |
 Abz-Arg-Val-Lys-Arg-Gly-Leu-Ala-m-nitro-Tyr-Asp-OH |
|||
| M-2115.0001 | Bachem | 1.0mg | EUR 261 |
|
Description: Sum Formula: C54H84N18O16; CAS# [174838-79-0] net |
|||
Abz-Arg-Val-Lys-Arg-Gly-Leu-Ala-m-nitro-Tyr-Asp-OH |
|||
| M-2115.0005 | Bachem | 5.0mg | EUR 950 |
|
Description: Sum Formula: C54H84N18O16; CAS# [174838-79-0] net |
|||
 M Antibody |
|||
| 1-CSB-PA322192LA01RAI | Cusabio |
|
|
|
|||
|
Description: A polyclonal antibody against M. Recognizes M from Rabies virus. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:1000-1:5000 |
|||
 Porcine Anti-PRRSV 1+2-NP antibody negative control serum |
|||
| RV-400120-PNC | Alpha Diagnostics | 1 ml | EUR 164 |
 Porcine Anti-PRRSV 1+2-NP antibody positive control serum |
|||
| RV-400120-PPC | Alpha Diagnostics | 1 ml | EUR 225 |
 Porcine Anti-PRRSV 1+2-NSP antibody negative control serum |
|||
| RV-400150-PNC | Alpha Diagnostics | 1 ml | EUR 164 |
 Porcine Anti-PRRSV 1+2-NSP antibody positive control serum |
|||
| RV-400150-PPC | Alpha Diagnostics | 1 ml | EUR 225 |
 Antibody) Human Apolipoprotein M (Apo M) Antibody |
|||
| 22525-05011 | AssayPro | 150 ug | EUR 217 |
 Antibody) Polyclonal Neurofilament M (NF-M) Antibody |
|||
| AMM06637G | Leading Biology | 0.1ml | EUR 484 |
|
Description: A polyclonal antibody raised in Chicken that recognizes and binds to Human Neurofilament M (NF-M) . This antibody is tested and proven to work in the following applications: |
|||
 antibody(IgG)ELISA kit) Pig reproductive and respiratory syndrome virus(PRRSV) antibody(IgG)ELISA kit |
|||
| CSB-EQ027198PI-24T | Cusabio | 1 plate of 24 wells | EUR 165 |
|
|||
|
Description: Qualitativeindirect ELISA kit for measuring Pig reproductive and respiratory syndrome virus (PRRSV) antibody (IgG) in samples from serum. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Pig reproductive and respiratory syndrome virus(PRRSV) antibody(IgG)ELISA kit |
|||
| 1-CSB-EQ027198PI | Cusabio |
|
|
|
|||
|
Description: Qualitativeindirect ELISA kit for measuring Pig reproductive and respiratory syndrome virus(PRRSV) antibody(IgG) in samples from serum. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
 Antibody) Centromere Protein M (CENPM) Antibody |
|||
| 20-abx210453 | Abbexa |
|
|
|
|||
Centromere Protein M (CENPM) Antibody |
|||
| 20-abx339098 | Abbexa |
|
|
|
|||
Centromere Protein M (CENPM) Antibody |
|||
| abx340223-100ug | Abbexa | 100 ug | EUR 391 |
|
|||
 Carboxypeptidase M antibody |
|||
| 22407-100ul | SAB | 100ul | EUR 390 |
 IRAK-M Antibody |
|||
| 24128-100ul | SAB | 100ul | EUR 390 |
Carboxypeptidase M antibody |
|||
| 70R-12966 | Fitzgerald | 100 ul | EUR 457 |
|
Description: Affinity purified Rabbit polyclonal Carboxypeptidase M antibody |
|||
 Oncostatin M antibody |
|||
| 70R-14205 | Fitzgerald | 100 ug | EUR 322 |
|
Description: Affinity purified Rabbit polyclonal Oncostatin M antibody |
|||
Oncostatin M antibody |
|||
| 70R-15253 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal Oncostatin M antibody |
|||
 M-CK Antibody |
|||
| 33654-100ul | SAB | 100ul | EUR 252 |
M-CK Antibody |
|||
| 33654-50ul | SAB | 50ul | EUR 187 |
 M-cadherin Antibody |
|||
| 39253-100ul | SAB | 100ul | EUR 390 |
 SARS M antibody |
|||
| 10R-1977 | Fitzgerald | 100 ul | EUR 241 |
|
Description: Mouse monoclonal SARS M antibody |
|||
 M-Ficolin antibody |
|||
| 10-1769 | Fitzgerald | 200 ul | EUR 543 |
|
Description: Mouse monoclonal M-Ficolin antibody |
|||
M-Ficolin antibody |
|||
| 10-1770 | Fitzgerald | 200 ul | EUR 543 |
|
Description: Mouse monoclonal M-Ficolin antibody |
|||
 Selenoprotein M antibody |
|||
| 10R-8406 | Fitzgerald | 100 ul | EUR 393 |
|
Description: Mouse monoclonal Selenoprotein M antibody |
|||
Selenoprotein M antibody |
|||
| 10R-8407 | Fitzgerald | 100 ul | EUR 393 |
|
Description: Mouse monoclonal Selenoprotein M antibody |
|||
 M-CSF Antibody |
|||
| 5237-100 | Biovision | EUR 316 | |
M-CSF Antibody |
|||
| 5237-30T | Biovision | EUR 146 | |
M-CSF Antibody |
|||
| 5238-100 | Biovision | EUR 316 | |
M-CSF Antibody |
|||
| 5238-30T | Biovision | EUR 146 | |
M-CK Antibody |
|||
| DF3072 | Affbiotech | 200ul | EUR 304 |
|
Description: M-CK Antibody detects endogenous levels of total M-CK. |
|||
 hnRNP M Antibody |
|||
| DF3201 | Affbiotech | 200ul | EUR 304 |
|
Description: hnRNP M Antibody detects endogenous levels of total hnRNP M. |
|||
 M-Calpain antibody |
|||
| 70R-CR017 | Fitzgerald | 100 ug | EUR 435 |
|
Description: Affinity purified Rabbit polyclonal M-Calpain antibody |
|||
 M-CSF antibody |
|||
| 70R-CR018 | Fitzgerald | 100 ug | EUR 381 |
|
Description: Affinity purified Rabbit polyclonal M-CSF antibody |
|||
M-CSF antibody |
|||
| 70R-MG004 | Fitzgerald | 50 ug | EUR 273 |
|
Description: Affinity purified Goat polyclonal M-CSF antibody |
|||
Oncostatin M antibody |
|||
| 70R-OR001 | Fitzgerald | 100 ug | EUR 381 |
|
Description: Affinity purified Rabbit polyclonal Oncostatin M antibody |
|||
Oncostatin M antibody |
|||
| 70R-OR002 | Fitzgerald | 50 ug | EUR 273 |
|
Description: Affinity purified Rabbit polyclonal Oncostatin M antibody |
|||
 M Cadherin antibody |
|||
| 70R-51487 | Fitzgerald | 100 ul | EUR 244 |
|
Description: Purified Polyclonal M Cadherin antibody |
|||
 M Cadherin Antibody |
|||
| 20-abx007556 | Abbexa |
|
|
|
|||
 M-Cadherin Antibody |
|||
| abx022459-100ug | Abbexa | 100 ug | EUR 1135 |
|
|||
 M JMJD3 Antibody |
|||
| abx025644-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
M JMJD3 Antibody |
|||
| abx025644-80l | Abbexa | 80 µl | EUR 286 |
|
|||
 M CD31 Antibody |
|||
| abx025991-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
M CD31 Antibody |
|||
| abx025991-80l | Abbexa | 80 µl | EUR 286 |
|
|||
 SARS-M Antibody |
|||
| abx016056-100ul | Abbexa | 100 ul | EUR 411 |
|
|||
 M Sh2d5 Antibody |
|||
| abx034943-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
M Sh2d5 Antibody |
|||
| abx034943-80l | Abbexa | 80 µl | EUR 286 |
|
|||
 M Tfap2c Antibody |
|||
| abx034980-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
M Tfap2c Antibody |
|||
| abx034980-80l | Abbexa | 80 µl | EUR 286 |
|
|||
M-cadherin Antibody |
|||
| abx037498-100ug | Abbexa | 100 ug | EUR 391 |
|
|||
M-CK Antibody |
|||
| 20-abx013363 | Abbexa |
|
|
|
|||
 M Sema5a Antibody |
|||
| abx031644-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
M Sema5a Antibody |
|||
| abx031644-80l | Abbexa | 80 µl | EUR 286 |
|
|||
M Sema5a Antibody |
|||
| abx031645-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
M Sema5a Antibody |
|||
| abx031645-80l | Abbexa | 80 µl | EUR 286 |
|
|||
 M Sirt3 Antibody |
|||
| abx032748-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
M Sirt3 Antibody |
|||
| abx032748-80l | Abbexa | 80 µl | EUR 286 |
|
|||
 M CCNB1 Antibody |
|||
| abx034751-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
M CCNB1 Antibody |
|||
| abx034751-80l | Abbexa | 80 µl | EUR 286 |
|
|||
 M Tcfap2d Antibody |
|||
| abx034886-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
M Tcfap2d Antibody |
|||
| abx034886-80l | Abbexa | 80 µl | EUR 286 |
|
|||
 M Abi3 Antibody |
|||
| abx034928-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
M Abi3 Antibody |
|||
| abx034928-80l | Abbexa | 80 µl | EUR 286 |
|
|||
 M Gpr68 Antibody |
|||
| abx034939-400ul | Abbexa | 400 ul | EUR 523 |
|
|||
M Gpr68 Antibody |
|||
| abx034939-80l | Abbexa | 80 µl | EUR 286 |
|
|||
hnRNP M Antibody |
|||
| AF0481 | Affbiotech | 200ul | EUR 304 |
|
Description: hnRNP M Antibody detects endogenous levels of hnRNP M. |
|||
hnRNP M Antibody |
|||
| AF5276 | Affbiotech | 200ul | EUR 304 |
|
Description: hnRNP M Antibody detects endogenous levels of total hnRNP M. |
|||
 C2GnT-M Antibody |
|||
| abx432431-200ul | Abbexa | 200 ul | EUR 384 |
|
|||
C2GnT-M Antibody |
|||
| abx432432-200ul | Abbexa | 200 ul | EUR 384 |
|
|||
 M- CK Antibody |
|||
| ABD3072 | Lifescience Market | 100 ug | EUR 438 |
hnRNP M Antibody |
|||
| ABD3201 | Lifescience Market | 100 ug | EUR 438 |
hnRNP M Antibody |
|||
| ABF0481 | Lifescience Market | 100 ug | EUR 438 |
hnRNP M Antibody |
|||
| ABF5276 | Lifescience Market | 100 ug | EUR 438 |
 Antibody) Heterogeneous Nuclear Ribonucleoprotein M (hnRNP M) Antibody |
|||
| abx146991-100ug | Abbexa | 100 ug | EUR 439 |
|
|||
Heterogeneous Nuclear Ribonucleoprotein M (hnRNP M) Antibody |
|||
| abx146992-100ug | Abbexa | 100 ug | EUR 439 |
|
|||
Heterogeneous Nuclear Ribonucleoprotein M (hnRNP M) Antibody |
|||
| 20-abx141106 | Abbexa |
|
|
|
|||
Heterogeneous Nuclear Ribonucleoprotein M (hnRNP M) Antibody |
|||
| abx011947-100ug | Abbexa | 100 ug | EUR 439 |
|
|||
 Oncostatin M protein |
|||
| 30R-2605 | Fitzgerald | 10 ug | EUR 302 |
|
Description: Purified recombinant Human Oncostatin M protein |
|||
 CMV-M protein |
|||
| 30R-AC082 | Fitzgerald | 1 ml | EUR 732 |
|
Description: Purified native Human CMV-M protein |
|||